Skip to main content
Clinical Trials/CTRI/2024/06/068847
CTRI/2024/06/068847
Not yet recruiting
Phase 2

eoadjuvant Radiotherapy in breast Cancer, A study on the optimal sequencing of radiation in breast cancer. - NeoORB

All India Institute of Medical Sciences, Jodhpur0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
All India Institute of Medical Sciences, Jodhpur
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
All India Institute of Medical Sciences, Jodhpur

Eligibility Criteria

Inclusion Criteria

  • 1\)Eligibility for NACT:
  • Patients with inoperable breast cancer:
  • a)Bulky or matted cN2 axillary nodes
  • b)cN3 nodal disease
  • c)cT4 tumors(Inflammatory breast cancer if disease can be contained in radiotherapy portal)
  • In select patients with operable breast cancer:
  • a)HER2\-positive disease and TNBC, if \=cT2 or \=cN1
  • b)Large primary tumor relative to breast size in a patient who desires breast conservation.
  • c)cN\+ disease likely to become cN0 with preoperative systemic therapy.
  • d)cT1c, cN0, HER2\-positive disease and TNBC.

Exclusion Criteria

  • 1\)Pregnancy or lactation
  • 2\)Prior radiotherapy of the affected or contralateral breast
  • 3\)Connective tissue disease, including rheumatoid arthritis and thromboangiitis obliterans
  • 4\)Cardiac comorbidities: symptomatic coronary heart disease, prior heart attack, heart failure NYHA II or AHA C, pacemaker, and/or implanted defibrillator
  • 5\)Other medical conditions that prohibit the neoadjuvant chemotherapy (i.e. psychiatric diseases, non\-compliance, etc.)
  • 6\)Patients with pure ductal carcinomas in situ.
  • 7\)Patients with non\-epithelial malignant conditions of the breast viz. Sarcomas, lymphomas, phyllodes tumors
  • 8\)Synchronous primary

Outcomes

Primary Outcomes

Not specified

Similar Trials